Delivery Order SPE2DR25D1103-SPE2DR26FF991
Award Date 3/18/26
Potential Completion Date 3/19/26
Potential Value $5.7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 11, 2026, for Zepbound 5 mg/0.5 mL pen with a ceiling value of $17,010.78. Place of performance is Conshohocken, PA. The ultimate completion date is March 12, 2026. This firm fixed-price delivery order was issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026,...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 18, 2026, for Zepbound 15 mg/0.5 mL pen with a ceiling value of $48,728.03. Place of performance is Conshohocken, PA. The order has a completion date of March 19, 2026 and is priced on a firm fixed-price basis. The delivery order was issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which covers pharmaceutical...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 18, 2026, for Zepbound 15 mg/0.5 ml pen with a ceiling value of $19,435.70 under firm fixed pricing. Place of performance is Conshohocken, PA. The order's ultimate completion date is March 19, 2026. This delivery order calls against the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026, which supports pharmaceutical...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 6, 2026, for Zepbound 12.5 mg/0.5 mL pen with a firm fixed price ceiling of $20,555.70. Place of performance is Conshohocken, PA. The order ultimate completion date is March 9, 2026. This delivery order was issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026,...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 13, 2026, for Zepbound 15 mg/0.5 mL pen with a ceiling value of $18,794.83. The order is placed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 global pharmaceutical supply vehicle running through December 2026. Place of performance is Conshohocken, PA. The order carries firm fixed pricing and was competitively awarded with no set-aside. Ultimate...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 3, 2026, for Zepbound 15 mg/0.5 mL pen with a firm fixed price of $1,095.11 and ultimate completion date of March 4, 2026. Place of performance is Conshohocken, PA. The delivery order was issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2026), which supplies pharmaceutical products and medical supplies to support military healthcare...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 13, 2026, for Zepbound 2.5 mg/0.5 ml pen with a ceiling value of $6,839.72, with final delivery due March 16, 2026. The order is issued under a parent Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken,...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 16, 2026, for Zepbound 5 mg/0.5 ml pen with a ceiling value of $10,578.10. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 5, 2026, for Zepbound 7.5 mg/0.5 ml pen 0.5 ml with a ceiling value of $27,758.16. Place of performance is Conshohocken, PA. The ultimate completion date is March 6, 2026. Pricing is firm fixed price. This delivery order was issued under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, which provides a comprehensive global...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 5, 2026, for Zepbound 5 mg/0.5 mL pen with a firm fixed price ceiling of $5,405.92. Place of performance is Conshohocken, Pennsylvania. The ultimate completion date is March 6, 2026. The order was issued on a non-set-aside basis. This delivery order is drawn against AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FF991Delivery Order
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 18, 2026, for Zepbound 15 mg/0.5 mL pen with a ceiling value of $5,657.91 under firm fixed pricing. Place of performance is Conshohocken, PA. The ultimate completion date is March 19, 2026. The delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Generated 6/17/26, 11:01 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 3/17/26 |